.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Farmers Insurance
Daiichi Sankyo
Novartis
Teva
Medtronic
US Department of Justice
Deloitte
US Army
Colorcon

Generated: September 22, 2017

DrugPatentWatch Database Preview

Prednisolone acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone acetate and what is the scope of prednisolone acetate patent protection?

Prednisolone acetate
is the generic ingredient in eighteen branded drugs marketed by Allergan, Cent Pharms, Akorn, Bel Mar, Pfizer, Watson Labs, Schering, Taro, Alcon, Novartis Pharms Corp, Pharmafair, Bausch And Lomb, and Novartis, and is included in twenty-seven NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Prednisolone acetate has thirty-three patent family members in fourteen countries.

There are eighty-six drug master file entries for prednisolone acetate. Ten suppliers are listed for this compound.

Summary for Generic Name: prednisolone acetate

Tradenames:18
Patents:4
Applicants:13
NDAs:27
Drug Master File Entries: see list86
Suppliers / Packagers: see list10
Bulk Api Vendors: see list40
Clinical Trials: see list1,289
Patent Applications: see list3,405
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prednisolone acetate at DailyMed

Pharmacology for Ingredient: prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
PREDNISOLONE ACETATE
prednisolone acetate
INJECTABLE;INJECTION084492-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bel Mar
PREDNISOLONE ACETATE
prednisolone acetate
INJECTABLE;INJECTION083738-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmafair
PREDSULFAIR
prednisolone acetate; sulfacetamide sodium
OINTMENT;OPHTHALMIC088032-001Apr 15, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
ISOPTO CETAPRED
prednisolone acetate; sulfacetamide sodium
SUSPENSION;OPHTHALMIC087547-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon
ECONOPRED
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017468-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Taro
FLO-PRED
prednisolone acetate
SUSPENSION;ORAL022067-002Jan 17, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Watson Labs
PREDNISOLONE ACETATE
prednisolone acetate
INJECTABLE;INJECTION083398-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Taro
FLO-PRED
prednisolone acetate
SUSPENSION;ORAL022067-001Jan 17, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Allergan
PRED MILD
prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC017100-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Taro
FLO-PRED
prednisolone acetate
SUSPENSION;ORAL022067-001Jan 17, 2008DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: prednisolone acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro
FLO-PRED
prednisolone acetate
SUSPENSION;ORAL022067-002Jan 17, 2008► Subscribe► Subscribe
Taro
FLO-PRED
prednisolone acetate
SUSPENSION;ORAL022067-002Jan 17, 2008► Subscribe► Subscribe
Taro
FLO-PRED
prednisolone acetate
SUSPENSION;ORAL022067-001Jan 17, 2008► Subscribe► Subscribe
Taro
FLO-PRED
prednisolone acetate
SUSPENSION;ORAL022067-001Jan 17, 2008► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: prednisolone acetate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,355,258 Method for formulating spill resistant pharmaceutical compositions in semi-solid form► Subscribe
8,461,139Oral suspension of prednisolone acetate► Subscribe
8,206,727Oral suspension of prednisolone acetate► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: prednisolone acetate

Country Document Number Estimated Expiration
Japan5161722► Subscribe
Australia765798► Subscribe
Japan2002516849► Subscribe
Israel140000► Subscribe
World Intellectual Property Organization (WIPO)9962498► Subscribe
Austria312598► Subscribe
China101247786► Subscribe
European Patent Office1632224► Subscribe
Canada2616112► Subscribe
Israel170790► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Colorcon
McKesson
AstraZeneca
Teva
Julphar
Cerilliant
Fish and Richardson
Covington
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot